Categories
Edgewell Personal Care Company (NYSE: EPC) today issued a voluntary nationwide recall of three batches of Banana Boat Hair & Scalp Sunscreen Spray SPF 30 to the consumer level as outlined in the table below. An internal review found that some samples of the product contained trace levels of benzen
Categories
FDA Seeks to Improve Patient Communication on LASIK Benefits and Risks Through Issuance of Draft Guidance
FDA Seeks to Improve Patient Communication on LASIK Benefits and Risks Through Issuance of Draft Guidance
http://www.fda.gov/news-events/press-announcements/fda-seeks-improve-patient-communication-lasik-benefits-and-risks-through-issuance-draft-guidance
Categories
FDA Roundup: July 26, 2022
FDA Roundup: July 26, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-26-2022
Categories
Vi-Jon, LLC Expands Voluntary Nationwide Recall of All Flavors and Lots Within Expiry of Magnesium Citrate Saline Laxative Oral Solution Due to Microbial Contamination
July 25, 2022 – Smyrna, TN, Vi-Jon, LLC is expanding its voluntary recall to include all lots of all flavors of Magnesium Citrate Saline Laxative Oral Solution within expiry to the consumer level. This expansion includes all lots of Cherry Flavor and Grape Flavor of Magnesium Citrate Saline Laxati
Categories
Baxter Healthcare Corporation Recalls Abacus Order Entry and Calculation Software for Risk of Medication Label Errors
User changes in the Abacus order entry and calculation software labeling templates may cause incorrect information to appear on final medication labels.
Categories
Ultra Supplement LLC Issues Voluntary Nationwide Recall of Sustango Due to the Presence of Undeclared Tadalafil
Wilmington DE, Ultra Supplement LLC is voluntarily recalling lot number DAP272109, exp 4/1/26 of Sustango capsules packaged in 10-count blisters packaged in a carton to the consumer level. Ultra Supplement was notified by Amazon that laboratory analysis has found the product to be tainted with tadal
Categories
FDA Roundup: July 22, 2022
FDA Roundup: July 22, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-22-2022
Categories
FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health
FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health
http://www.fda.gov/news-events/press-announcements/fda-details-optimized-approach-regulatory-oversight-tools-better-protect-public-health
Categories
Voluntary Recall of Certain Over-the-Counter Products
Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently shipped to certain stores on or around May 1, 2022 through June 10, 2022 due to product being stored outside of labeled
Categories
FDA Warns Against Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication
Renuvion/J-Plasma has not been cleared for Aesthetic Skin Procedures. FDA warns patients & health care providers of potential risks.